小胶质细胞CD31抑制Aβ清除并促进5×FAD小鼠阿尔茨海默病理进展
Microglial CD31 suppresses Aβ clearance and promotes Alzheimer pathology in 5×FAD mice
Zhou Qiuzhi, Sun Fei, Zhang Yao, Cao Xiaojian, Li Mengzhu, Yu Haitao, Jiang Tao, Li Shihong, Wang Weixia, Xie Jiazhao, He Ting, Liu Yanchao, Ke Dan, Wang Xiao-Chuan, Xu Peng, Liu Enjie, Chen Hong, Wang Jian-Zhi
Journal:Nature Communications
IF:18.1
DOI:10.1038/s41467-026-74037-5
PMID:
Published:2026-06-05
research field:神经科学分子生物学药理学免疫学神经退行性疾病
Abstract
Microglia play crucial roles in Alzheimer's disease (AD), yet the molecular mechanisms are unclear. Here, we show that CD31, a recognized endothelial marker, is predominantly expressed in microglia but not in neurons or astrocytes, and it is significantly elevated in the brains of AD patients and mouse models. Microglia-specific CD31 knockdown in 5xFAD mice substantially attenuated the dysregulated transcription networks, suppressed microglia hyperactivation and the disease-associated microglia (DAM), mitigated Aβ deposition and inflammation, and eventually improved cognitive functions in mice. Mechanistically, CD31 knockdown damaged the simultaneous recruitment of Src homology phosphatase 2 (SHP2) and STAT3, leading to a reduced dephosphorylation and enhanced activation of STAT3, a transcription factor. STAT3 activation increased transcription of membrane metalloendopeptidase (MME) and promoted Aβ clearance. Collectively, this study identifies microglial CD31, by regulating SHP2-STAT3-MME axis, plays a role in AD pathogenesis and targeting CD31 is promising in AD drug development.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


